Combination therapy for sleep disordered breathing and heart failure

US2016135734A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016135734-A1
Application numberUS-201514944626-A
CountryUS
Kind codeA1
Filing dateNov 18, 2015
Priority dateNov 19, 2014
Publication dateMay 19, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and apparatus provide evaluation of a cardiac condition of a patient with sleep disordered breathing. One or more processors, such as processors associated with any of ICDs, CRTs and/or respiratory pressure therapy devices, may be configured to receive data representing one or more respiratory parameters for the patient. The processor(s) may receive cardiac-related patient data for the patient. The processor(s) may determine a presence of a smooth hemodynamic baseline from the received data representing one or more respiratory parameters for the patient. The processors may evaluate the cardiac condition of the patient from the received cardiac-related patient data based on the determined presence of the smooth hemodynamic baseline.

First claim

Opening claim text (preview).

1 . A method for evaluating a cardiac condition of a patient with sleep disordered breathing comprising: receiving data representing one or more respiratory parameters for the patient; receiving cardiac-related patient data for the patient; determining in a processor a presence of a smooth hemodynamic baseline from the received data representing one or more respiratory parameters for the patient; and evaluating, with the processor, the cardiac condition of the patient from the received cardiac-related patient data based on the determined presence of the smooth hemodynamic baseline. 2 . The method of claim 1 wherein the determining comprises detecting absence of sleep disordered breathing events for a predetermined period of time. 3 . The method of claim 1 wherein the determining comprises: detecting sleep disordered breathing events; and controlling a respiratory therapy to alleviate the detected sleep disordered breathing events for a predetermined period of time. 4 . The method of claim 1 further comprising collecting, with one or more sensors, data representing one or more hemodynamic parameters for the patient while the patient is within the smooth hemodynamic baseline. 5 . The method of claim 4 , wherein the evaluating is based on the data representing one or more hemodynamic parameters. 6 . The method of claim 3 wherein the controlling comprises controlling a respiratory pressure therapy device to deliver respiratory pressure therapy for the patient. 7 . The method of claim 6 , wherein the respiratory pressure therapy comprises an adaptive servo-ventilation therapy. 8 . The method of claim 2 wherein the sleep disordered breathing events comprise one or more of apnea, hypopnea, Cheyne-Stokes respiration, snoring and flow limitation. 9 . The method of claim 3 , wherein the controlling comprises controlling an implanted device to provide at least one of genioglossal nerve stimulation and phrenic nerve stimulation. 10 . The method of claim 1 , further comprising determining, based on the evaluating, efficacy of a cardiac treatment that has been provided to the patient. 11 . The method of claim 10 , wherein the cardiac treatment comprises one or more of administering a pharmaceutical cardiac drug and application of a cardiac resynchronization therapy. 12 . The method of claim 10 , further comprising titrating the cardiac treatment according to the cardiac condition of the patient. 13 . The method of claim 12 wherein the titration of the cardiac treatment comprises determination of a diuretic dose. 14 . The method of claim 12 wherein the titration of the cardiac treatment comprises an adjustment to a target ventilation of a respiratory pressure therapy. 15 . The method of claim 14 wherein the respiratory pressure therapy is a pressure support ventilation therapy controlled in accordance with the target ventilation. 16 . The method of claim 5 wherein the evaluating comprises outputting one or more hemodynamic parameters according to a time period of the smooth hemodynamic baseline. 17 . The method of claim 5 wherein the evaluating comprises detecting a change in one or more hemodynamic parameters within a time period initiated with the smooth hemodynamic baseline. 18 . The method of claim 1 wherein the received cardiac-related patient data comprises measurements generated by a pulmonary artery sensor. 19 . The method of claim 1 wherein the received data representing one or more respiratory parameters comprises measurements generated by a Doppler radar motion sensor. 20 . A system for evaluating a cardiac condition of a patient with sleep disordered breathing comprising: one or more memories; and one or more processors in communication with the one or more memories, the one or more processors configured to: receive data representing one or more respiratory parameters for the patient; receive cardiac-related patient data for the patient; determine a presence of a smooth hemodynamic baseline from the received data representing one or more respiratory parameters for the patient; and evaluate the cardiac condition of the patient from the received cardiac-related patient data for the patient based on the determined presence of the smooth hemodynamic baseline. 21 . The system of claim 20 wherein determination of the presence of the smooth hemodynamic baseline comprises detecting absence of sleep disordered breathing events for a predetermined period of time. 22 . The system of claim 20 wherein determination of the presence of the smooth hemodynamic baseline comprises detecting sleep disordered breathing events and controlling a respiratory therapy to alleviate the detected sleep disordered breathing events for a predetermined period of time. 23 . The system of claim 20 further comprising collecting, with one or more sensors, cardiac-related patient data while the patient is within the smooth hemodynamic baseline. 24 . The system of claim 23 wherein evaluation of the cardiac condition is based on the cardiac-related patient data. 25 . The system of claim 20 further comprising a respiratory pressure therapy apparatus, the apparatus configured to alleviate detected sleep disordered breathing events by controlling a respiratory pressure therapy for the patient. 26 . The system of claim 25 , wherein the respiratory pressure therapy comprises an adaptive servo-ventilation therapy. 27 . The system of claim 21 wherein the sleep disordered breathing events comprise one or more of apneas, hypopneas, Cheyne-Stokes respiration, snoring, and flow limitation. 28 . The system of claim 20 , further comprising an implanted device configured to alleviate sleep disordered breathing events by controlling providing at least one of genioglossal nerve stimulation and phrenic nerve stimulation. 29 . The system of claim 20 , wherein the one or more processors is further configured to determine, based on the evaluating, efficacy of a cardiac treatment that has been provided to the patient. 30 . The system of claim 29 , wherein the cardiac treatment comprises one or more of administering a pharmaceutical cardiac drug and providing a cardiac resynchronization therapy. 31 . The system of claim 29 , wherein the evaluation further comprises titration of the cardiac treatment according to the cardiac condition of the patient. 32 . The system of claim 31 wherein the cardiac treatment comprises a diuretic dose and the titration comprises determining the diuretic dose. 33 . The system of claim 31 wherein the titration of the cardiac treatment comprises an adjustment to a target ventilation of a respiratory pressure therapy. 34 . The system of claim 33 wherein the respiratory pressure therapy is a pressure support ventilation therapy controlled in accordance with the target ventilation and provided by an adaptive servo-ventilator of the system. 35 . The system of claim 20 wherein the evaluation comprises outputting, by the one or more processors, one or more hemodynamic parameters according to a time period of the smooth hemodynamic baseline. 36 . The system of claim 20 wherein the evaluation comprises detecting by the one or more processors a change in

Assignees

Inventors

Classifications

  • using physiological parameters · CPC title

  • the speed thereof being controlled by respiratory parameters, e.g. by inhalation · CPC title

  • Respiration control (stimulating respiratory organs A61N1/3601) · CPC title

  • Devices for facilitating collection of breath or for directing breath into or through measuring devices · CPC title

  • A61B5/4818Primary

    Sleep apnoea · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016135734A1 cover?
Methods and apparatus provide evaluation of a cardiac condition of a patient with sleep disordered breathing. One or more processors, such as processors associated with any of ICDs, CRTs and/or respiratory pressure therapy devices, may be configured to receive data representing one or more respiratory parameters for the patient. The processor(s) may receive cardiac-related patient data for the …
Who is the assignee on this patent?
Resmed Ltd
What technology area does this patent fall under?
Primary CPC classification A61B5/4818. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).